Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 2 |
2021 | 3 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Normalization of serum B-cell maturation antigen levels predicts overall survival among multiple myeloma patients starting treatment.
Br J Haematol. 2021 Jan;192(2):272-280. doi: 10.1111/bjh.16752. Epub 2020 May 22.
Br J Haematol. 2021.
PMID: 32441777
Free article.
Serum B-cell maturation antigen (sBCMA) is a novel biomarker for B-cell malignancies. A normal reference range (<82.59 ng/ml) has been recently established but the impact of achieving normal levels to outcomes for patients receiving treatment for B-cell ma …
Serum B-cell maturation antigen (sBCMA) is a novel biomarker for B-cell malignancies. A normal reference range (<82.59 ng/m …
Estimating a normal reference range for serum B-cell maturation antigen levels for multiple myeloma patients.
Jew S, Bujarski S, Soof C, Chen H, Safaie T, Li M, Sanchez E, Wang C, Emamy-Sadr M, Swift R, Rahbari A, Patil S, Souther E, Spektor TM, Berenson JR.
Jew S, et al.
Br J Haematol. 2021 Mar;192(6):1064-1067. doi: 10.1111/bjh.16673. Epub 2020 Apr 22.
Br J Haematol. 2021.
PMID: 32321191
Free article.
The serum B-cell maturation antigen (sBCMA) has been identified as a novel serum biomarker for patients with multiple myeloma. ...
The serum B-cell maturation antigen (sBCMA) has been identified as a novel serum biomarker for patients with multiple myeloma. ...
Item in Clipboard
Baseline and Changes in Serum B-Cell Maturation Antigen Levels Rapidly Indicate Changes in Clinical Status Among Patients with Relapsed/Refractory Multiple Myeloma Starting New Therapy.
Bujarski S, Udd K, Soof C, Chen H, Spektor TM, Safaie T, Li M, Stern J, Wang C, Xu N, Emamy-Sadr M, Swift R, Rahbari A, Patil S, Souther E, Regidor B, Sutanto C, Berenson JR.
Bujarski S, et al.
Target Oncol. 2021 Jul;16(4):503-515. doi: 10.1007/s11523-021-00821-6. Epub 2021 Jun 7.
Target Oncol. 2021.
PMID: 34097243
BACKGROUND: B-cell maturation antigen (BCMA) is expressed on malignant plasma cells from patients with multiple myeloma (MM). ...
BACKGROUND: B-cell maturation antigen (BCMA) is expressed on malignant plasma cells from patients with multiple myeloma (MM). ...
Item in Clipboard
Cite
Cite